journal article·2025-09

Fatty acid albumin conjugates mechanically weaken and disrupt degradation of fibrin networks

Yujen Wang, Sajjad Norouzi, Arsalan Nisar, Justin Houser, Sachin Kumar, Mohammadhasan Hedayati, H. Samet Varol, Paula Delgado, Naomi Calhoun, Leah Gutzwiller, Jeanne C. Stachowiak, Manuel K. Rausch, Sapun H. Parekh

Acta Biomaterialia· Volume 204
Publisher page

Abstract

Cardiovascular diseases and stroke together account for the largest causes of death in Western countries. These pathologies are directly linked to the formation of blood clots that block blood flow to vital organs. Common risk factors for such clots are obesity, high blood pressure, diabetes, and high LDL cholesterol. Immediate thrombolytic treatment to dissolve fibrin-rich clots can save lives, but recent research has shown that pure fatty acids (FA) can inhibit thrombolysis via interaction with plasmin. However, since FAs are often complexed to serum albumin in the blood, it is unclear how FAs in blood interact with plasmin, or perhaps with clots, to modulate thrombolysis. Here, we studied how elevated levels of two abundant FAs (oleic and palmitic acid) complexed to bovine serum albumin (BSA) affect fibrin hydrogels and their degradation. We observed the binding of fatty acid-BSA (FABSA) conjugates to fibrin via Förster resonance energy transfer microscopy and noted the effects of FABSA on fibrin gels mechanics and fibrinolysis compared to pure fibrin networks. Specifically, with FABSA in the fibrin network, fibrin hydrogels were mechanically weakened and showed a significant decrease in fibrinolysis speed. These studies show that elevated fatty acid content modifies clot properties, making them mechanically weaker and more resistant to degradation. STATEMENT OF SIGNIFICANCE: Fibrin networks are the primary load-bearing element in blood clots, which are subject to various cyclic forces in the body and have excellent mechanical properties resulting from fibrin's hierarchical structure. These networks are formed in the presence fatty acids, lipoproteins, and albumin in the blood; however, little is known about how these additional constituents modify fibrin network properties. By imaging protein fiber orientation, molecular structure, and degradation in situ, we find that fibrin formation in the presence of elevated fatty acids conjugated to albumin modifies network structure, mechanically weakens fibrin networks, and slows fibrin network degradation considerably. Based on our findings, we suspect that increased fat in blood may lead impeded fibrin degradation and increased clot persistence.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Blood properties and coagulation · Diabetes, Cardiovascular Risks, and Lipoproteins · Proteins in Food Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (76)

Show source-provided references
1. Heart Disease and Stroke Statistics—2021 Update | Circulation, (n.d.). https://www.ahajournals.org/doi/10.1161/CIR.0000000000000950 (accessed May 26, 2021).
2. D. Mozaffarian, E.J. Benjamin, A.S. Go, D.K. Arnett, M.J. Blaha, M. Cushman, S.R. Das, S. de Ferranti, J.-P. Després, H.J. Fullerton, V.J. Howard, M.D. Huffman, C.R. Isasi, M.C. Jiménez, S.E. Judd, B.M. Kissela, J.H. Lichtman, L.D. Lisabeth, S. Liu, R.H. Mackey, D.J. Magid, D.K. McGuire, E.R.M. Iii, C.S. Moy, P. Muntner, M.E. Mussolino, K. Nasir, R.W. Neumar, G. Nichol, L. Palaniappan, D.K. Pandey, M.J. Reeves, C.J. Rodriguez, W. Rosamond, P.D. Sorlie, J. Stein, A. Towfighi, T.N. Turan, S.S. Virani, D. Woo, R.W. Yeh, M.B. Turner, Heart disease and stroke statistics—2016 update, (n.d.) 324.10.1161/CIR.0000000000000366 ↗
3. Death rates by marital status for leading causes of Death: united States, 2010–2019, (n.d.) 17.
4. Why fibrin biomechanical properties matter for hemostasis and thrombosis10.1111/jth.15531 ↗
5. The mechanical properties of fibrin for basic scientists and clinicians10.1016/j.bpc.2004.07.029 ↗
6. Fibrin mechanical properties and their structural origins10.1016/j.matbio.2016.08.003 ↗
7. Structural hierarchy governs fibrin gel mechanics10.1016/j.bpj.2010.01.040 ↗
8. Structural control of fibrin bioactivity by mechanical deformation10.1073/pnas.2117675119 ↗
9. Beyond established and novel risk factors-lifestyle risk factors for cardiovascular disease10.1161/CIRCULATIONAHA.107.738732 ↗
10. Fibrinogen and fibrin clot structure in diabetes10.1007/s00059-004-2607-z ↗
11. Obesity and free fatty acids10.1016/j.ecl.2008.06.007 ↗
12. Identification of fibrin clot-bound plasma proteins10.1371/journal.pone.0041966 ↗
13. Albumin as fatty acid transporter10.2133/dmpk.24.300 ↗
14. Fatty acid binding to plasma albumin10.1016/S0022-2275(20)36723-7 ↗
15. Fatty acids and inflammation: the cutting edge between food and pharma10.1016/j.ejphar.2011.05.085 ↗
16. Polyunsaturated fatty acids and inflammation10.1016/j.plefa.2006.05.012 ↗
17. Dietary fatty acids and the haemostatic system10.1016/j.atherosclerosis.2004.10.010 ↗
18. (IUCr) Small- and wide-angle elastic light scattering study of fibrin structure10.1107/S0021889803003947 ↗
19. Plasminogen activator inhibitor-1 and relations to fatty acid composition in the diet and in serum cholesterol esters10.1161/hq1201.100224 ↗
20. Unsaturated fatty acids increase plasminogen activator inhibitor-1 expression in endothelial cells10.1161/01.ATV.18.11.1679 ↗
21. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake10.1016/j.plipres.2008.03.003 ↗
22. Fatty acid binding to human serum albumin: new insights from crystallographic studies
23. Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids11Edited by R. Huber10.1006/jmbi.2000.5208 ↗
24. Missing regions within the molecular architecture of human fibrin clots structurally resolved by XL-MS and integrative structural modeling10.1073/pnas.1911785117 ↗
25. Efficient one-step PEG-silane passivation of glass surfaces for single-molecule fluorescence studies10.1021/acsami.8b15796 ↗
26. Probing fibrin’s molecular response to shear and tensile deformation with coherent Raman microscopy10.1016/j.actbio.2020.12.020 ↗
27. Bridging chains mediate nonlinear mechanics of polymer nanocomposites under cyclic deformation10.1016/j.polymer.2020.122529 ↗
28. A Förster resonance energy transfer-based sensor of steric pressure on membrane surfaces10.1021/jacs.0c09802 ↗
29. Microscale spatial heterogeneity of protein structural transitions in fibrin matrices10.1126/sciadv.1501778 ↗
30. Label-free cellular imaging by broadband Coherent anti-stokes raman scattering microscopy10.1016/j.bpj.2010.08.009 ↗
31. Label-free imaging of lipophilic bioactive molecules during lipid digestion by Multiplex Coherent Anti-Stokes Raman Scattering Microspectroscopy10.1021/ja102069d ↗
32. Influence of fibrin network conformation and fibrin Fiber diameter on fibrinolysis speed10.1161/01.ATV.20.5.1354 ↗
33. What is the diameter of a fibrin fiber?10.1016/j.rpth.2023.100285 ↗
34. The applicability of current turbidimetric approaches for analyzing fibrin fibers and other filamentous networks10.3390/biom12060807 ↗
35. Nonlinear, dissipative phenomena in whole blood clot mechanics10.1039/D0SM01317J ↗
36. Rupture of blood clots: mechanics and pathophysiology10.1126/sciadv.abc0496 ↗
37. Fibrin networks support recurring mechanical loads by adapting their structure across multiple scales10.1016/j.bpj.2016.06.034 ↗
38. Strain history dependence of the nonlinear stress response of fibrin and collagen networks10.1073/pnas.1222787110 ↗
39. Similar nonlinear mechanical responses in hard and soft materials10.1038/nmat3603 ↗
40. Strain-enhanced stress relaxation impacts nonlinear elasticity in collagen gels10.1073/pnas.1523906113 ↗
41. Cell locomotion and focal adhesions are regulated by substrate flexibility10.1073/pnas.94.25.13661 ↗
42. Evidence of a phospholipid binding species within Human fibrinogen preparations10.1016/S0049-3848(99)00058-4 ↗
43. G. Burger, Förster Resonance Energy Transfer (FRET), (2011). https://www.leica-microsystems.com/science-lab/foerster-resonance-energy-transfer-fret/ (accessed November 12, 2022).
44. Resonance energy transfer: methods and applications10.1006/abio.1994.1134 ↗
45. Accelerating SNARE-mediated membrane fusion by DNA–Lipid tethers10.1002/anie.201506844 ↗
46. Single-molecule FRET states, conformational interchange, and conformational selection by Dye Labels in Calmodulin10.1021/acs.jpcb.6b00864 ↗
47. Multiscale mechanics of fibrin polymer: gel stretching with protein unfolding and loss of water10.1126/science.1172484 ↗
48. Strain tunes proteolytic degradation and diffusive transport in fibrin networks10.1021/bm2015619 ↗
49. The α-helix to β-sheet transition in stretched and compressed hydrated fibrin clots10.1016/j.bpj.2012.07.046 ↗
50. Mechanical transition from α-helical coiled coils to β-sheets in fibrin(ogen)10.1021/ja3076428 ↗
51. Raman spectroscopy of biological tissues10.1080/05704920701551530 ↗
52. D. González-García, D. Giordano, A. Allabar, F. Andrade, L. Polo, V. Janasi, A. Lucchetti, K. Hess, C.D. de Campos, D. Dingwell, Retrieving dissolved H2O content from micro-raman spectroscopy on nanolitized silicic glasses: application to volcanic products of the Paraná Magmatic Province, Brazil, (2021). https://doi.org/10.1016/J.CHEMGEO.2021.120058.10.1016/j.chemgeo.2021.120058 ↗
53. Quantification of dissolved H2O in silicate glasses using confocal microRaman spectroscopy10.1016/j.chemgeo.2006.01.014 ↗
54. Correlation of O-H stretching frequencies and O-H…O hydrogen bond lengths in minerals10.1007/BF03354882 ↗
55. Clot or not? Reviewing the reciprocal regulation between lipids and blood clotting10.1161/ATVBAHA.123.318286 ↗
56. Metabolism and functions of phosphatidylserine10.1016/j.plipres.2005.05.001 ↗
57. Intracellular tPA–PAI-1 interaction determines VLDL assembly in hepatocytes10.1126/science.adh5207 ↗
58. Weight reduction is associated with increased plasma fibrin clot lysis10.1177/1076029613486016 ↗
59. Molecular and physical mechanisms of fibrinolysis and thrombolysis from mathematical modeling and experiments10.1038/s41598-017-06383-w ↗
60. Synthetic hydrogels as blood clot mimicking wound healing materials10.1088/2516-1091/ac23a4 ↗
61. Inhibition of plasmin-mediated prostromelysin-1 activation by interaction of long chain unsaturated fatty acids with kringle 510.1016/j.bcp.2003.09.033 ↗
62. Regulation of fibrinolysis by non-esterified fatty acids10.1042/bj3000251 ↗
63. Suppressed catalytic efficiency of plasmin in the presence of long-chain fatty acids10.1111/j.1742-4658.2008.06288.x ↗
64. Reduced thrombin formation and altered fibrin clot properties induced by polyunsaturated omega-3 fatty acids on top of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention (OMEGA-PCI clot)10.1161/ATVBAHA.111.228593 ↗
65. The X-ray crystal structure of full-length Human plasminogen10.1016/j.celrep.2012.02.012 ↗
66. The refined structure of the. Epsilon.-aminocaproic acid complex of human plasminogen kringle 410.1021/bi00107a030 ↗
67. Investigation of binding of fatty acids to serum albumin to determine free concentrations: experimental and in-silico approaches10.1016/j.aca.2021.339370 ↗
68. The extraordinary ligand binding properties of human serum albumin10.1080/15216540500404093 ↗
69. Structural basis of the drug-binding specificity of human serum albumin10.1016/j.jmb.2005.07.075 ↗
70. Location of high and low affinity fatty acid binding sites on Human serum albumin revealed by NMR drug-competition analysis10.1016/j.jmb.2006.06.028 ↗
71. Interplay of platelet contractility and elasticity of fibrin/erythrocytes in blood clot retraction10.1016/j.bpj.2017.01.005 ↗
72. Blood clot contraction differentially modulates internal and external fibrinolysis10.1111/jth.14370 ↗
73. Nanoparticle amount, and not size, determines chain alignment and nonlinear hardening in polymer nanocomposites
74. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial10.1002/hep.26185 ↗
75. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis10.1002/hep.21930 ↗
76. Albumin dialysis MARS: knowledge from 10 years of clinical investigation10.1097/MAT.0b013e3181b37d86 ↗